The course of neuropathy after cessation of cisplatin treatment, combined with Org 2766 or placebo
- 1 March 1992
- journal article
- clinical trial
- Published by Springer Nature in Zeitschrift für Neurologie
- Vol. 239 (3) , 143-146
- https://doi.org/10.1007/bf00833914
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Prevention of Cisplatin Neurotoxicity with an ACTH(4–9) Analogue in Patients with Ovarian CancerNew England Journal of Medicine, 1990
- Vibration perception and thermoperception as quantitative measurements in the monitoring of cisplatin induced neurotoxicityJournal of the Neurological Sciences, 1989
- Efficacy of the neuropeptide ORG.2766 in the prevention and treatment of cisplatin-induced neurotoxicity in ratsEuropean Journal of Cancer and Clinical Oncology, 1988
- Unusual presentation of cis‐platinum NeuropathyNeurology, 1988
- Electrophysiological study of the peripheral and central neurotoxic effect of cis-platinActa Neurologica Scandinavica, 1987
- High-dose cisplatin administration without hypertonic saline: observation of disabling neurotoxicity.Journal of Clinical Oncology, 1985
- Polyneuropathy Induced by CisplatinPublished by S. Karger AG ,1984
- Peripheral sensory neuropathy and cisplatin chemotherapyNeurology, 1984
- Evidence that the neurotrophic actions of α-MSH may derive from its ability to mimick the actions of a peptide formed in degenerating nerve stumpsJournal of the Neurological Sciences, 1984
- Standardised method of determining vibratory perception thresholds for diagnosis and screening in neurological investigation.Journal of Neurology, Neurosurgery & Psychiatry, 1979